DAWNRAYS PHARMA (02348) repurchased 232,000 shares on November 2 for HK$213,600.
DAWNRAYS PHARMA (02348) announced that on November 2, 2026, the company repurchased 232,000 shares for HK$213,600, at a repurchase price of HK$0.915-0.925 per share.
DAWNRAYS PHARMA (02348) announced that on November 2, 2026, the company repurchased 232,000 shares for HK$213,600, at a repurchase price of HK$0.915-0.925 per share.
Related Articles
SAINT BELLA GP (02508) repurchased 1.3295 million shares on November 2 for approximately HK$2.8872 million.
CHINA JINMAO (00817): Issues 4.818 million scrip shares under the 2026 interim scrip dividend arrangement
CICC (03908) completes issuance of RMB3 billion corporate bonds.
SAINT BELLA GP (02508) repurchased 1.3295 million shares on November 2 for approximately HK$2.8872 million.
CHINA JINMAO (00817): Issues 4.818 million scrip shares under the 2026 interim scrip dividend arrangement
CICC (03908) completes issuance of RMB3 billion corporate bonds.
